We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report Absolves Merck of Ignoring Vioxx Risks, Slams 'Poor Judgment'
The item has been added to your shopping cart.
Report Absolves Merck of Ignoring Vioxx Risks, Slams 'Poor Judgment'
September 8, 2006
Authors of a new report say it exonerates Merck from allegations that the company knowingly kept its painkiller Vioxx on the market despite underlying cardiovascular risks, but investigators also condemn Merck’s “poor judgment and errors,” including public statements that downplayed the health hazards.